Showing results (341-350 of 398) with videos related to

Sort By:
Pageof 40
World Journal of Gastroenterology|April 21, 2015
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinomaMin-Young Lee, Ki Sun Jung, Hae Su Kim, et al.
European Urology|October 1, 2023
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind TrialNobuaki Matsubara, Ronald de Wit, Arjun Vasant Balar, et al.
The Lancet. Oncology|May 15, 2021
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trialEvan Y Yu, Daniel P Petrylak, Peter H O'Donnell, et al.
European Journal of Haematology|March 17, 2009
Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromesChan H Park, Bruce F Kimler, Seong Yoon Yi, et al.
Nature Medicine|July 18, 2018
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancerSeung Tae Kim, Razvan Cristescu, Adam J Bass, et al.
International Journal of Radiation Oncology, Biology, Physics|August 16, 2005
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomachSung Kim, Do Hoon Lim, Jeeyun Lee, et al.
Plos One|February 2, 2013
A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancersJeeyun Lee, Sung Kim, Phillip Kim, et al.
The New England Journal of Medicine|March 6, 2024
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial CancerThomas Powles, Begoña P Valderrama, Shilpa Gupta, et al.
American Journal of Clinical Oncology|August 2, 2002
Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancerKihyun Kim, Eunmi Nam, Nam Soo Lee, et al.
JCO Global Oncology|July 8, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 StudyMimma Rizzo, Andrey Soares, Shilpa Gupta, et al.
Pageof 40